MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
4.450
-0.020 (-0.45%)
May 27, 2026, 1:28 PM EDT - Market open
MacroGenics Employees
MacroGenics had 293 employees as of December 31, 2025. The number of employees decreased by 48 or -14.08% compared to the previous year.
Employees
293
Change (1Y)
-48
Growth (1Y)
-14.08%
Revenue / Employee
$536,119
Profits / Employee
-$240,130
Market Cap
282.84M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 293 | -48 | -14.08% |
| Dec 31, 2024 | 341 | 2 | 0.59% |
| Dec 31, 2023 | 339 | -18 | -5.04% |
| Dec 31, 2022 | 357 | -70 | -16.39% |
| Dec 31, 2021 | 427 | 57 | 15.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AC Immune | 122 |
| Niagen Bioscience | 117 |
| Zentalis Pharmaceuticals | 106 |
| Silence Therapeutics | 88 |
| SAB Biotherapeutics | 86 |
| Protara Therapeutics | 46 |
| Surrozen | 44 |
| Inhibikase Therapeutics | 35 |
MGNX News
- 7 days ago - MacroGenics Transcript: Stifel 2026 Targeted Oncology Virtual Forum - Transcripts
- 12 days ago - MacroGenics to Participate in the Stifel 2026 Virtual Targeted Oncology Forum - GlobeNewsWire
- 13 days ago - MacroGenics reports Q1 EPS (58c), consensus (55c) - TheFly
- 13 days ago - MacroGenics Reports First Quarter 2026 Financial Results and Highlights Business Transformation - GlobeNewsWire
- 14 days ago - MacroGenics Quarterly report: Q1 2026 - Filings
- 14 days ago - MacroGenics Earnings release: Q1 2026 - Filings
- 15 days ago - MacroGenics to sell GMP manufacturing operations to Bora for $122.5M upfront - TheFly
- 15 days ago - MacroGenics trading resumes - TheFly